Abstract
See article on page 343 As the field of anticancer gene therapy edges closer to the mainstream, so we learn more of its current limitations as well as the potential...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
